Investigation Overview
June 22, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), was announced concerning whether the takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders. The investigation by a law firm concerns whether certain office...
You must register (for free) or login to view the entire investigation.